Sepsis Diagnostics Market Growth Analysis by Product, Application, Region-Forecasts 2021-2031 | bioMérieux, Becton, Dickinson and Company, Danaher Corporation

The global sepsis diagnostics market was valued at USD 503.4 million in 2021 and it is anticipated to grow up to USD 1181.5 million by 2031, at a CAGR of 8.9% during the forecast period.

New York, According to a new market research report published by Global Insight Services Sepsis Diagnostics Market is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Sepsis is a potentially fatal illness that arises when the body's immune system attacks its own tissues in reaction to an infection. When the infection-fighting processes turn on the body, they cause organs to function poorly and abnormally. Septic shock can develop from sepsis. This is a sudden reduction in blood pressure that can cause serious organ damage and even death. Treatment with antibiotics and intravenous fluids as soon as possible enhances the chances of survival.

Read more about Sepsis Diagnostics Market here : https://www.globalinsightservices.com/reports/sepsis-diagnostics-market

Market Trends and Drivers

Rising incidence of hospital-acquired infections will augment the market growth during the forecast period. Hospital-acquired infections (HAIs), also known as nosocomial infections, are a major cause of morbidity and mortality worldwide. The most common hospital-acquired infections (HAIs) are urinary tract infections, pneumonia, and sepsis. HAIs can lead to sepsis in immunocompromised patients, geriatric patients, and patients suffering from chronic illnesses. In the U.S., the incidence of sepsis among hospitalized patients is rising by 8.7% per year. It is estimated that there are more than 1,000,000 incidences of sepsis among hospitalized patients annually in the nation {Source: CDC, 2018). With the rapid increase in HAIs worldwide, the demand for sepsis diagnostic products is also expected to rise in the coming years.

Download a Free PDF Sample Copy of Report : https://www.globalinsightservices.com/request-sample/GIS10358

Market Restraints and Challenges

High cost of automated diagnostic devices may hamper the industry growth. The cost of molecular diagnostic tests is between USD 300 and USD 3,000, which is very high compared to the cost of blood culture tests, priced as low as ~USD 28-35. Companies focus on developing automated diagnostic devices based on advanced technologies, such as molecular diagnostics, on detecting sepsis but due to limited budgets, government hospitals (especially in emerging nations) and academic research laboratories cannot afford such systems. Further, becoming the major factor for the hindrance of the growth of sepsis diagnostics market.

Global Sepsis Diagnostics Market Segmental Overview

The report analyses the global sepsis diagnostics market based on product, technology, pathogen, testing type, end use, and region.

Global Sepsis Diagnostics Market by Product

Based on product, it is segmented into instruments, blood culture media, and assay kits and reagents. The blood culture media segment accounted for the largest share of market during the forecast period. This share can be attributed to the growing utilization of blood culture media by hospitals & pathology laboratories for the diagnosis of sepsis coupled with an increase in the availability of blood culture media in the market. Additionally, blood culture is considered to be the most convenient and cost-effective mode of testing by clinicians. Hence, aforementioned aspect is expected to fuel the segmental growth.

Major Players in the Global Sepsis Diagnostics Market

The key players in the market are bioMérieux (France), Becton, Dickinson and Company (US), Danaher Corporation (US), T2 Biosystems (US), Luminex (US), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (US), Bruker Corporation (US) and Abbott Laboratories (US), among others.

Get Customized report as per your requirements : https://www.globalinsightservices.com/request-customization/GIS10358

Reasons to buy Sepsis Diagnostics Market Report:

• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.